Elevance Health, Inc. (ELV)
439.95
-5.33
(-1.20%)
USD |
NYSE |
Oct 23, 16:00
440.02
+0.07
(+0.02%)
After-Hours: 20:00
Elevance Health Enterprise Value : 125.95B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 125.95B |
| October 22, 2026 | 127.10B |
| October 21, 2026 | 124.69B |
| October 20, 2026 | 126.00B |
| October 19, 2026 | 123.85B |
| October 16, 2026 | 123.42B |
| October 15, 2026 | 123.46B |
| October 14, 2026 | 123.39B |
| October 13, 2026 | 122.78B |
| October 12, 2026 | 122.09B |
| October 09, 2026 | 120.06B |
| October 08, 2026 | 117.52B |
| October 07, 2026 | 118.25B |
| October 06, 2026 | 117.34B |
| October 05, 2026 | 116.13B |
| October 02, 2026 | 114.38B |
| October 01, 2026 | 113.35B |
| September 30, 2026 | 114.90B |
| September 29, 2026 | 116.34B |
| September 28, 2026 | 116.75B |
| September 25, 2026 | 117.07B |
| September 24, 2026 | 117.54B |
| September 23, 2026 | 117.61B |
| September 22, 2026 | 118.45B |
| September 21, 2026 | 119.94B |
| Date | Value |
|---|---|
| September 18, 2026 | 120.29B |
| September 17, 2026 | 121.01B |
| September 16, 2026 | 120.64B |
| September 15, 2026 | 121.72B |
| September 14, 2026 | 123.18B |
| September 11, 2026 | 121.98B |
| September 10, 2026 | 121.51B |
| September 09, 2026 | 117.25B |
| September 08, 2026 | 118.34B |
| September 04, 2026 | 119.55B |
| September 03, 2026 | 121.12B |
| September 02, 2026 | 119.19B |
| September 01, 2026 | 118.58B |
| August 31, 2026 | 116.30B |
| August 28, 2026 | 116.71B |
| August 27, 2026 | 117.73B |
| August 26, 2026 | 118.47B |
| August 25, 2026 | 117.67B |
| August 24, 2026 | 118.49B |
| August 21, 2026 | 118.04B |
| August 20, 2026 | 117.11B |
| August 19, 2026 | 117.58B |
| August 18, 2026 | 117.54B |
| August 17, 2026 | 115.80B |
| August 14, 2026 | 117.99B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| The Cigna Group | 113.11B |
| Centene Corp. | 50.86B |
| CVS Health Corp. | 182.00B |
| Humana, Inc. | 64.99B |
| UnitedHealth Group, Inc. | 454.12B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 1.343B |
| Revenue (Quarterly) | 51.43B |
| Total Expenses (Quarterly) | 50.06B |
| EPS Diluted (Quarterly) | 6.273 |
| Profit Margin (Quarterly) | 2.61% |
| Earnings Yield | 5.33% |
| Operating Earnings Yield | 7.97% |
| Normalized Earnings Yield | 5.332 |